Healix

Real-World Comparison of Arthralgias with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease

Selected as a Poster of Distinction

Presented on January 23, 2020

Authors:
Timothy E. Ritter, MD – GI Alliance, Southlake, TX
Chris Fourment, MD – GI Alliance, Southlake, TX
Samantha A. Mehta, PharmD – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound